Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients

類似資料

• VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.
  著者:: Jian-Ming Li, 等
  出版事項: (2013-01-01)
• VIPhyb, an Antagonist of Vasoactive Intestinal Peptide Receptor, Enhances Cellular Antiviral Immunity in Murine Cytomegalovirus Infected Mice
  著者:: Li, Jian-Ming, 等
  出版事項: (2013)
• Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant
  著者:: Lu, Ying, 等
  出版事項: (2009)
• Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
  著者:: Boland, G J, 等
  出版事項: (1992)
• Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
  著者:: Stern, Lauren, 等
  出版事項: (2019)